NCT04153669

Brief Summary

This study aims to assess the effects of programmed exercise with or without electrical stimulation in the cardiorespiratory fitness, strength, functional capacity and agility in a group of young patients with Cystic Fibrosis: A randomized controlled trial comparing two interventions with a control group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2019

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 30, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 6, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 9, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 9, 2020

Completed
Last Updated

July 24, 2020

Status Verified

July 1, 2020

Enrollment Period

1.1 years

First QC Date

October 30, 2019

Last Update Submit

July 23, 2020

Conditions

Keywords

Cystic FibrosisElectrostimulationCombined TrainingPhysical Fitness

Outcome Measures

Primary Outcomes (1)

  • Change in Strength

    Changes in strength will be measured using a five repetition maximum test (5RM)

    Two assessment points throughout the study: baseline and 8 weeks after the intervention

Secondary Outcomes (5)

  • Change in Cardiorespiratory Fitness

    Two assessment points throughout the study:baseline and 8 weeks after the intervention

  • Changes in Pulmonary Function

    Two assessment points throughout the study:baseline and 8 weeks after the intervention

  • Changes in physical activity levels

    Two assessment points throughout the study:baseline and 8 weeks after the intervention

  • Change in quality of life

    Two assessment points throughout the study:baseline and 8 weeks after the intervention

  • Food consumption frequency

    One assessment point at baseline:baseline and 8 weeks after the intervention

Study Arms (3)

Control

NO INTERVENTION

This group will continue with regular visits to the specialist. This visits include recommendations to improve lifestyle.

Exercise-No NMES

EXPERIMENTAL

This group will continue with regular visits to the specialist. This visits include recommendations to improve lifestyle. The exercise protocol includes a concurrent exercise intervention (strength training and aerobic training), 3 days a week, 60 minutes sessions.

Behavioral: Exercise-No NMES

Exercise-NMES

EXPERIMENTAL

This group will continue with regular visits to the specialist. This visits include recommendations to improve lifestyle. The exercise protocol includes a concurrent exercise intervention (strength training and aerobic training), 3 days a week, 60 minutes sessions. Additionally, this group will receive neuromuscular electrical stimulation (NMES) concomitant to the strength training.

Behavioral: Exercise-NMES

Interventions

Exercise-NMESBEHAVIORAL

Exercise-NMES

Exercise-NMES

Exercise-No NMES

Exercise-No NMES

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Diagnosis of CF
  • Age: 6-18 years old
  • Signature of informed consent of legal guardian and patient.

You may not qualify if:

  • Being a smoker
  • Having had an exacerbation in the last 3 months
  • Having undergone gastric surgery
  • Having enteral nutrition at present
  • The patients will come from the HIUNJ of Madrid.
  • Currently taking CFTR modulators

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Escuela de Doctorado e Investigacion, Universidad Europea

Villaviciosa de Odón, 28670, Spain

Location

MeSH Terms

Conditions

Cystic Fibrosis

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, Diseases

Study Officials

  • Margarita Perez Ruiz, MD

    Universidad Europea de Madrid

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor in Exercise Physiology, MD, PhD

Study Record Dates

First Submitted

October 30, 2019

First Posted

November 6, 2019

Study Start

January 15, 2019

Primary Completion

March 9, 2020

Study Completion

March 9, 2020

Last Updated

July 24, 2020

Record last verified: 2020-07

Locations